Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Aprocitentan, on top of background therapy, showed clinically meaningful and durable blood pressure (BP) reduction and a decrease in proteinuria in Black patients with confirmed resistant hypertension...
-
CASP Conference, May 14-16, 2025 fosters diverse insights on suicide prevention and life promotion with pre-conference Healing Day on May 13, 2025.
-
MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of Anne Whitaker...
-
SPARK NS announces the eight projects selected to receive aggregate funding of up to $16 million to advance academic discoveries in Parkinson’s disease
-
MONTREAL, April 02, 2025 (GLOBE NEWSWIRE) -- The McGill University Health Centre (MUHC) Foundation is proud to announce the successful completion of its ambitious Dream Big campaign, which has...
-
MELBOURNE, Australia, April 02, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase 1...
-
PsyCan Excoriates Trudeau Government for Making Assisted Suicide Harder than Psychedelic-Assisted Therapy; Calls on Carney and Poilievre to do better
-
SAN DIEGO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) is pleased to announce that Andrew Cardno, Chief Technology & Growth Officer (CTO) at QCI, will be...
-
Increased survival and reduced major adverse cardiac and cerebrovascular events (MACCE) observed study-wide, despite primary composite efficacy endpoint not reaching statistical...
-
Current policies may benefit Tesla and increase vulnerability to United States.